Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

[1] Collet JP(2021)2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 42 1289-1367

[2] Thiele H(2018)2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 39 119-177

[3] Barbato E(2014)2014 AHA/ACC Guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 e139-e228

[4] Barthélémy O(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 485-510

[5] Bauersachs J(2012)Statins in acute coronary syndrome: very early initiation and benefits Ther Adv Cardiovasc Dis 6 163-174

[6] Bhatt DL(2013)Early differential changes in coronary plaque composition according to plaque stability following statin initiation in acute coronary syndrome: classification and analysis by intravascular ultrasound-virtual histology Yonsei Med J 54 336-344

[7] Ibanez B(2015)Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies BMC Med 13 229-1252

[8] James S(2013)Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies Am J Cardiol 111 1246-e159

[9] Agewall S(2013)Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms Thromb Res 131 e154-321

[10] Antunes MJ(2016)Stabilization of high-risk plaques Cardiovasc Diagn Ther 6 304-1632

[1] Collet JP(2021)2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 42 1289-1367

[2] Thiele H(2018)2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 39 119-177

[3] Barbato E(2014)2014 AHA/ACC Guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 e139-e228

[4] Barthélémy O(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 485-510

[5] Bauersachs J(2012)Statins in acute coronary syndrome: very early initiation and benefits Ther Adv Cardiovasc Dis 6 163-174

[6] Bhatt DL(2013)Early differential changes in coronary plaque composition according to plaque stability following statin initiation in acute coronary syndrome: classification and analysis by intravascular ultrasound-virtual histology Yonsei Med J 54 336-344

[7] Ibanez B(2015)Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies BMC Med 13 229-1252

[8] James S(2013)Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies Am J Cardiol 111 1246-e159

[9] Agewall S(2013)Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms Thromb Res 131 e154-321

[10] Antunes MJ(2016)Stabilization of high-risk plaques Cardiovasc Diagn Ther 6 304-1632